Sign Up to like & get
recommendations!
0
Published in 2025 at "Pharmacogenomics and Personalized Medicine"
DOI: 10.2147/pgpm.s527556
Abstract: Purpose We aimed to determine the prevalence of interactions between PGx drugs metabolized by CYP2C9, CYP2C19, and CYP2D6 and drugs that act as inhibitors or inducers of those enzymes in the Swiss population. Patients and…
read more here.
Keywords:
potential drug;
claims data;
drug;
prevalence potential ... See more keywords